AzTrials
AzTrials

Proximal Junctional KyphosisTRANSITIONNCT07618897

Efficacy of Sub-laminar and/or Interspinous Tethers to Prevent Proximal Junctional Kyphosis After Surgical Correction of Adult Spinal Deformity

A study testing Tether strategy and Reference in people with Proximal Junctional Kyphosis, run by Hospices Civils de Lyon at 6 sites in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

PJK (proximal junctional kyphosis) at the upper end of spinal fusions after surgical correction of adult spinal deformity is not uncommon. Two-thirds of cases are observed within the first 3 months after surgery and 80% within the first 18 months. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Proximal Junctional Kyphosis
What is being tested?
Tether strategy and Reference
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
6 sitesFrance
Study dates
22 Oct 2026to 22 Jun 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient men and women older than 18
  • Patient indicated spinal posterior fusion and instrumentation with the upper end (UIV with screws) between T9 and L2 and the lower end between L5 and iliac
  • Constructs ≥4 levels (i.e., ≥4 discs included)
  • Patient able to signed a consent form
  • Patient able to fill a self-administered questionnaire
  • Patient affiliated to health care insurance (social security in France

Who cannot join

  • Allergy to metal
  • Cimentoplasty at the junctional zone (UIV, UIV+1 and/or UIV+2)
  • Bone metabolism disorders that potentially compromise the mechanical support expected from this type of implant.
  • Morbid obesity (BMI > 40)
  • Patients with infection (in particularly osteomyelitis)
  • Cancer of lesss than 5 years or currently treated
Show all 17Show fewer
  • Acute trauma
  • Immunodepression
  • Parkinson
  • Chronic inflammatory disease
  • Severe psychological disorders
  • Pregnancy or women breastfeeding
  • Inadequate tissue coverage of implant site,
  • Interference with other critical anatomical structures.
  • Patient not being able to understand the objectives of the study or refusing to comply with postoperative instructions
  • Patient participating in an ongoing study that may interfere with this study
  • Patient under legal protection

Trial locations and contacts

6 sites in 1 country. Contact the study team or a site near you to ask about taking part.

6 sites in 1 country

France6 sites
  • CHU Bordeaux

    Bordeaux, 33000

    Benjamin BOUYER, MD, PU-PH, +33 5 57 82 26 26, b.bouyer@chu-bordeaux.fr

    Benjamin BOUYER, MD, PU-PH

  • CHU Limoges

    Limoges, 87000

    François CAIRE, MD, PU-PH, +33 5 55 05 65 21, francois.caire@chu-limoges.fr

    François CAIRE, MD, PU-PH

  • Hôpital Pierre Wertheimer - Hospices Civils de Lyon, Service de Neurochirurgie - Chirurgie du Rachis et de la Moëlle Epinière

    Lyon, 69394

    Cédric BARREY, Ph, +33 4 72 11 80 67, cedric.barrey@chu-lyon.fr

    Julien BERTHILLER, +33 4 27 85 63 01, julien.berthiller@chu-lyon.fr

  • AP-HM CHU La Timone

    Marseille, 13005

    Stéphane FUENTES, MD, PU-PH, +33 4 91 38 55 45, Stephane.FUENTES@ap-hm.fr

    Stéphane FUENTES, MD, PU-PH

  • AP-HP Hopital Européen Georges Pompidou

    Paris, 75015

    Emmanuelle FERRERO, MD, PU-PH, +33 1 56 09 57 00, emmanuelle.ferrero@aphp.fr

    Emmanuelle FERRERO, MD, PU-PH

  • CHRU Tours

    Tours, 37044

    Aymeric AMELOT, MD, PU-PH, +33 2 47 47 37 16, a.amelot@chu-tours.fr

    Aymeric AMELOT, MD, PU-PH

Other trials in France

About this study

Official title: Efficacy of Sub-laminar and/or Interspinous Tethers to Prevent Proximal Junctional Kyphosis After Surgical Correction of Adult Spinal Deformity - Randomized Multicentric Single Blind Controlled Trial

PJK (proximal junctional kyphosis) at the upper end of spinal fusions after surgical correction of adult spinal deformity is not uncommon. Two-thirds of cases are observed within the first 3 months after surgery and 80% within the first 18 months. PJK is consequently a common problem after surgery for adult spinal deformity, representing one of the most frequent complications following this kind of procedure. Although the first-line treatment of this event is conservative, surgery may be necessary in around 30-40% of cases. Revision surgery generally consists of extending the posterior spinal instrumentation.

Prophylactic vertebroplasty has been proposed to reduce the risk of PJK and PJF, with promising results but with the limitation of reinforcing only the bony structures, with no action on the soft tissues. In this context, some authors have reported that the use of tethers, creating a transitional zone at the upper end of the construct between the fused and the non-instrumented spine, could reduce the occurrence of this complication (PJK). One of the hypotheses is that the use of a topping-off system results in a transitional zone reducing stresses at the junctional spine and may reduce the occurrence of both PJK and the need for reoperation.

Read more

Compared with other topping-off systems, such as hooks, the surface of contact provided by the bands on the posterior arches is much greater and the primary stability much better. In addition, the risk of malposition is extremely low.

The aim of this study is therefore to compare the occurrence of PJK and PJF in patients for whom tethers were implanted at the upper end of the instrumentation versus patients for whom no tether system was used.

In a retrospective study conducted in the neurosurgery department of the HCL on 38 patients undergoing multilevel spine instrumentation with junctional tethers, PJK occurred in 8 of them (21%) after 24 months of follow-up.

Being tested
Tether strategy, Reference

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tether strategyDevice

    During spine surgery sub-laminar or interspinous bands are utilized in combination with standard posterior rigid instrumentation (i.e. screws and metallic rods). They are typically implanted at the upper vertebral level, above the cranial screws, and then connected to the rods. Their implantation is based on standard surgical techniques for spine surgeons.

  • ReferenceProcedure or surgery

    Patient will undergo the spine surgery as the standard of care, using only standard posterior rigid instrumentation (i.e. screws and metallic rods).

Study groups in NCT07618897
Study groupRoleWhat they receive
Patient instrumented with a tetherExperimentalSub-laminar and/or interspinous tethers
Receives: Device: Tether strategy
Reference strategyActive comparatorStandard surgery
Receives: Procedure: Reference

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sub-laminar and/or interspinous tethers efficacy to prevent PJK

    Percentage of patients with PJK during the first post-operative 24 months with PJK defined as :

    • a proximal junctional sagittal Cobb angle (PJA) between the lower endplate of uppermost instrumented vertebra (UIV) with screws and the upper endplate of 2 supra-adjacent vertebra ≥15
    • a 15° delta between 24months post operative PJA and preoperative PJA These 2 parameters will be assessed by an independent committee using radiographic images preop and 24 months postop

    Measured: From enrollment to 24 months post-surgery

Secondary outcomes (7)
  1. Sub-laminar and/or interspinous tethers efficacy to prevent PJF

    Comparison between the 2 randomized groups with or without tethers at 24 months: Percentage of patients with PJF, defined as a progressive process in the spectrum of PJK with structural failures such as vertebral body fracture and/or posterior ligament complex, and vertebral subluxation

    Measured: From enrollment to 24 months post-surgery

  2. Sub-laminar and/or interspinous tethers efficacy to prevent surgery revision

    Percentage of patients with an indication of revision surgery

    Measured: From enrollment to 24 months post-surgery

  3. Sub-laminar and/or interspinous tethers efficacy to prevent the level of disabilty

    Disability assed with Oswestry Disability Index questionnaire. It is composed of questions on the following items : pain intensity, personal care (washing, dressing), lifting objects, moving around, sitting or standing, sleeping, sex life, social life, and travel/transportation. Each items is scored from 0 to 5, 0 being absence of disability and 5 the most severe disability. The final score range from 0 to 50 and there is 6 level of disability according to final score categories: 0-4 no disability, 5-14 light disability, 15-24 moderate disability, 25-34 severe disability and 35-50 complete disability.

    Measured: From enrollment to 24 months post-surgery

  4. Sub-laminar and/or interspinous tethers efficacy to prevent pain

    Evolution of radicular and lumbar Pain assessed with a Visual Analogic Scale rated from 0 to 10, 0 being the absence of pain and 10 the worst pain ever experienced.

    Measured: From enrollment to 24 months post-surgery

  5. Sub-laminar and/or interspinous tethers efficacy to enhance quality of life

    Evolution of the mean Quality-of-Life score will be assessed using the EQ-5D-5L questionnaire. The EQ-5D-5L, developed by the EuroQol Group to improve sensitivity and reduce ceiling effects, includes two components: the descriptive system and the visual analogue scale (EQ VAS). The descriptive system covers five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), each rated on five levels from no problems to extreme problems, generating a 5-digit health state code. The EQ VAS records the patient's self-rated health on a vertical scale ranging from the best to the worst imaginable health, providing a quantitative measure based on the patient's own judgement.

    Measured: From enrollment to 24 months post-surgery

  6. Sub-laminar and/or interspinous tethers efficacy to prevent post-operative complications

    The number of peri- and post-operative complications including mechanical complication due to the device, infections, neurological and general complications.

    Measured: From enrollment to 24 months post-surgery

  7. Assess the efficiency of implanting tethers at the upper part of the construct in patient with an indication for spinal posterior fusion performing cost-utility and cost-effectiveness analyses

    Incremental cost-utility and cost-effectiveness ratios of implanting tethers at the upper part of the construct (tethers group) compare to the standard procedure without tethers at 24 months post-surgery.

    Measured: From enrollment to 24 months post-surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2026
  2. Study start22 Oct 2026 (estimated)
  3. Primary completion22 Jun 2030 (estimated)
  4. Study completion22 Jun 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07618897
Sponsor's protocol ID
69HCL24_0720
Other IDs
2026-A00732-49
Acronym
TRANSITION
Status last verified
Sep 2026
First submitted
13 May 2026
Last updated
28 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Tether strategy and Reference in people with Proximal Junctional Kyphosis, run by Hospices Civils de Lyon at 6 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Cédric BARREY, Ph (+33 4 72 11 80 67, cedric.barrey@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sub-laminar and/or interspinous tethers efficacy to prevent PJK (time frame: From enrollment to 24 months post-surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in